Coming Soon
Bymetric is Launching Soon
Open main menu
Innovate UK Funded
Public Funded Companies
Spinout Companies
News
Register
Login
View notifications
Innovate UK Funded
Spinout Companies
New Companies
News
Hubspot Companies House Data
Register
Login
Omass Therapeutics is a biotechnology company focused on using its proprietary platform technology to discover and develop new therapies for autoimmune and inflammatory diseases by harnessing the power of the immune system.
omass.com
LinkedIn
Twitter
Spinout Company
Public Funding Received
2018-03-01
A new platform for drug discovery for membrane protein targets
Collaborative R&D